Our services
Request an appointment
Reserve your spot with our medical team in just minutes.
What Is PT-141?
PT-141 works completely differently than traditional sexual dysfunction treatments. Most medications like Viagra target blood vessels – they increase blood flow to improve physical arousal. PT-141 goes straight to the brain.
Specifically, it targets melanocortin receptors (MC3R and MC4R) in your hypothalamus – the region that controls sexual motivation, arousal, and satisfaction at a neurochemical level (Annals of the New York Academy of Sciences). By stimulating these receptors, PT-141 restores the neural pathways that drive desire itself.
The FDA approved PT-141 under the brand name Vyleesi in June 2019, specifically for acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women, following multiple clinical studies that proved that PT-141 significantly increased satisfying sexual events and reduced the personal distress associated with low libido.
Using PT-141 off-label (for men, or postmenopausal women, or general libido optimization) is legal under physician supervision, but it’s important you understand that distinction. At Medical Cosmetic Enhancements, every patient receives full informed consent and physician evaluation before beginning PT-141 therapy.
How PT-141 Compares to Other Sexual Health Treatments
|
Treatment
|
Mechanism
|
Addresses Desire
|
FDA-Approved for Women
|
On-Demand Use
|
|---|---|---|---|---|
|
PT-141 (Bremelanotide) |
Central – melanocortin receptors |
Yes
|
Yes (premenopausal HSDD) |
Yes
|
|
Flibanserin (Addyi) |
Central – serotonin/dopamine |
Yes |
Yes (premenopausal HSDD) |
No (daily pill) |
|
PDE5 Inhibitors (e.g., sildenafil) |
Peripheral – vasodilation |
No |
No |
Yes |
|
Hormone Therapy |
Hormonal |
Partial |
Varies by formulation |
No (ongoing) |
How PT-141 Pairs with Other Services
For patients seeking comprehensive women’s wellness, PT-141 complements several services at Medical Cosmetic Enhancements.
ThermiVa – our radiofrequency vaginal rejuvenation treatment – addresses the physical and structural side of sexual wellness: dryness, laxity, and urinary changes. PT-141 addresses the neurological desire component. Together, they offer a more complete picture of sexual health.
Some patients also find that optimizing sleep and recovery through Sermorelin therapy reduces the fatigue and chronic stress that commonly suppress libido – a useful complement to PT-141’s direct mechanism.
What DC-Area Patients Should Expect
At our downtown DC clinic, a PT-141 consultation involves a review of sexual health history, relevant lab work where indicated, a thorough discussion of expectations, and full informed consent regarding the FDA-approved indication and any off-label use.
We take a sensitive, non-judgmental approach – sexual health deserves the same clinical seriousness as any other dimension of wellness.
Our practice serves patients from across the DC, Maryland, and Virginia metro area. Whether you are navigating the hormonal shifts of perimenopause, dealing with libido suppressed by stress and fatigue, or seeking treatment for longstanding HSDD, we can discuss whether PT-141 is appropriate for your situation.
Frequently Asked Questions
The FDA approval covers premenopausal women with HSDD. Off-label use in men – for low libido where standard treatments are insufficient – is practiced under physician supervision, but this use is outside the FDA-approved indication and should be clearly understood.
PT-141 works through a different pathway than hormones. It may be effective on its own or as part of a broader protocol that includes hormonal evaluation. Your physician will help determine the right approach.
PT-141 can cause transient blood pressure increases. Patients on antihypertensive medications should discuss this carefully with their provider. A full medication review is part of the consultation process.
Effects typically begin within 45 minutes and last 6–8 hours. Unlike daily medications, PT-141 is used only as needed – which many patients find appealing.
Coverage varies. Some plans cover Vyleesi for diagnosed HSDD, others do not. Our team will assist with any documentation needed for coverage inquiries.
Reclaim an Important Part of Your Wellbeing
Sexual desire is a legitimate and important component of quality of life. If low libido has been affecting your relationships or sense of self, PT-141 offers a clinically validated, FDA-approved option worth discussing with a physician.
Medical Cosmetic Enhancements approaches sexual wellness with the same expertise and discretion we bring to every service we offer.
Call (202) 621-8675 or request a confidential consultation at our Washington, DC office.